Latest Senores Pharmaceuticals stock price

Senores Pharmaceuticals P/E Ratio

SENORES • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
45.41
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 45.41
Current Price ₹864.70
EPS (TTM) ₹16.12
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 27.33
Historical Range 27.33 - 27.33
Percentile 100.0%

Sector Context

Sector Average 57.46
Sector Median 35.38
Sector Rank #11 of 88
Sector Percentile 12.5%

Earnings Breakdown (TTM)

TTM EPS ₹18.87
Sept 2025 ₹6.54
Mar 2025 ₹3.81

Key P/E Ratio Insights for Senores Pharmaceuticals

  • Stock appears overvalued with PE of 45.41, suggesting caution for new investments
  • Current PE is 66.2% above historical average
  • Trading at discount to sector average PE of 57.46

View the SENORES equity price for detailed stock performance.

P/E Ratio Historical Trend for Senores Pharmaceuticals

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 27.33 20.38 ₹557.05 NSE High

Sector P/E Ratio Comparison

Comparing Senores Pharmaceuticals with other companies in Healthcare sector
Sector Average
57.46
Sector Median
35.38
Lowest P/E
9.01
Highest P/E
515.32
Companies
88
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low
QMS Medical Allied Servi… QMSMEDI 12.82 ₹177 Low
Take Solutions TAKE 13.15 ₹638 Low
Venus Remedies VENUSREM 14.27 ₹995 Low
Royal Sense ROYAL 14.5 ₹96 Low
Bliss GVS Pharma BLISSGVS 16.62 ₹1,973 Moderate
RPG Life Sciences RPGLIFE 17.94 ₹3,861 Moderate